Virtual Agents-based Digital Interventions to Improve Health

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Bordeaux

About this trial

KANOPEE is a free smartphone application providing screening, follow-up tools and autonomous digital interventions to lower psycho-social stress and its repercussions on sleep and behaviors in the general population.

Additionally, KANOPEE permits an adaptation of the intervention to the subject (i.e., an adapted waiting period, frequency, and content), enabling to perform innovative trial conditions.

The objective of this long-term study is to evaluate the efficacy of KANOPEE on users among the French general population exposed to psycho-social stress.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Being aged 18 years old and over (the app is available for younger users but their data will not be analyzed)

having downloaded the app

having a smartphone Android or Iphone

being located in France

Disqualifiers

having clicked on the "emergency button" (in the app, there is a warning message : this app is not for emergency situations. If you need an urgent psychological support, click here")

having downloaded the app but without answering any questionnaire

Trial design

Design model

Parallel

Treatments tested in this trial

  • digital behavioral intervention

    Behavioral

    interaction with a conversational agent to implement physical and cognitive programs

Treatment groups

20,000 Participants
are divided into 2 treatment groups
Group A: digital behavioral interventionExperimental treatment 1 intervention
Group B: e-diariesNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Sleep complaints

measured by the Insomnia Severity Index (ISI), total score ranging from 0 to 28, higher score indicating higher sleep complaint.

Time frame
weekly, from the downloading of the app until two weeks after the end of the intervention
2

Fatigue complaints

measured by the Fatigue Severity Scale (FSS), total score ranging from 1 to 7, higher score indicating higher perceived fatigue.

Time frame
weekly, from the downloading of the app until two weeks after the end of the intervention
3

Depression and anxiety complaints

measured by the Patient Health Questionnaire 4 items (PHQ-4), total score ranging from 0 to 12, higher scores indicating higher depression or anxiety complaints.

Time frame
weekly, from the downloading of the app until two weeks after the end of the intervention

Secondary outcomes

1

Total Sleep Time

calculated based on the sleep diary data, corresponding to the actual time slept (Time in Bed - Sleep Onset Latency - Wakefulness After Sleep Onset - Terminal Wakefulness) (in hh:mm:ss)

Time frame
daily, from the downloading of the app until two weeks after the end of the intervention
2

Sleep Efficiency

calculated based on the sleep diary data, corresponding to the percent of time in bed spent asleep (Total Sleep Time/Time in Bed \* 100) (percentage)

Time frame
daily, from the downloading of the app until two weeks after the end of the intervention
3

Time In Bed

calculated based on the sleep diary data, time starting from the moment of intention to fall asleep and concluding with the final arising (in hh:mm:ss).

Time frame
daily, from the downloading of the app until two weeks after the end of the intervention
4

Sleep Onset Latency

calculated based on the sleep diary data, corresponding to the time it takes to fall asleep, starting from the moment of intention to fall asleep (in hh:mm:ss)

Time frame
daily, from the downloading of the app until two weeks after the end of the intervention

Other outcomes

1

application's acceptance

measured by the Acceptability of E-health Scale (AES), total score ranging from 0 to 30, higher score indicating a better acceptance of the app

Time frame
facultative questionnaire that user can fill up after any interaction with the app (thus weekly)

Sponsors and contacts

Click on the lead sponsor to view all of their trials.